IP Library Granted Patent US 7,714,011
Granted Patent B2
US 7,714,011 · App. 10/663,010 · Granted May 11, 2010

Compositions to reduce congestion and methods for application thereof to the nasal membrane

Assignee: Zicam, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,714,011
App. No.
10/663,010
Granted
May 11, 2010
Kind
B2
Abstract

A gelled composition formulated to maintain an active ingredient in association with the nasal membrane for an extended period of time is provided. The gelled composition may be formulated as a decongestant or a sinus discomfort relieving agent. The invention further includes a system and method for applying the gelled composition to the nasal membrane.

Claims (56)

1. A composition for application to a nasal membrane, the composition comprising:

about 90 to about 99.999 weight percent of a carrier;

0.000001 to 5.0 wt % thickener comprising one or more compounds selected from the group consisting of glycerin, carrageenan, sugar, guar gum, methylcellulose, and hydroxyethylcellulose;

about 0.001 to about 5.0 weight percent of at least one active ingredient comprising oxymetazoline hydrochloride; and

about 0.00001 to about 5.0 weight percent of a permeation enhancer comprising liposomes;

wherein the composition is a gelled matrix and has a viscosity between about 2,500 and about 40,000 centipoise, as measured according to ASTM D1824-87.

2. A composition for application to a nasal membrane, the composition comprising:

about 90 to about 99.999 weight percent of a carrier;

0.000001 to 5.0 wt % thickener comprising one or more compounds selected from the group consisting of glycerin, carrageenan, sugar, guar gum, methylcellulose, and hydroxyethylcellulose;

about 0.001 to about 5.0 weight percent of at least one active ingredient comprising oxymetazoline hydrochloride;

about 0.00001 to about 5.0 weight percent of a permeation enhancer comprising liposomes; and

about 0.000001 to about 1.0 weight percent of an aromatic substance comprising at least one of menthol or eucalyptus oil;

wherein the composition has a viscosity between about 2,500 and about 40,000 centipoise, as measured according to ASTM D1824-87.

3. A composition for application to a nasal membrane, the composition consisting of:

about 0.045 wt % to about 0.055 wt % oxymetazoline;

less than 5.0% by weight of at least one vitamin;

about 0.00001 wt % to about 5.0 wt % permeation enhancer;

about 0.000001 wt % to about 1.0 wt % aromatic substance selected from the group consisting of camphor, eucalyptus oil, menthol, azulen, extracts thereof, and mixtures thereof;

0.00001% to about 1.0% by weight of aloe vera powder;

about 0.000 1 wt % to about 1.0 wt preservative;

about 0.000001 to about 5.0 wt % thickener selected from the group consisting of glycerin, carrageenan, sugar, guar gum, methyl cellulose, and hydroxyethylcellulose;

0.05% to about 5.0% by weight glycerin;

about 90 wt % to about 99 wt % water;

about 0.00001 wt % to about 1.0 wt emulsion agent; and

about 0.0002 wt % to about 6.0 wt % buffer.

4. The composition of claim 3 , wherein the composition has a viscosity of about 2,500 cp to about 40,000 cp, as measured according to ASTM D1824-87.

5. The composition of claim 3 , wherein the composition has a viscosity of about 3,000 cp to about 10,000 cp, as measured according to ASTM D1824-87.

6. The composition of claim 3 , wherein the composition has a viscosity of about 4,000 cp to about 6,000 cp, as measured according to ASTM D1824-87.

7. The composition of claim 3 , wherein the composition has a viscosity of about 5,000 cp to about 40,000 cp, as measured according to ASTM D1824-87.

8. The composition of claim 3 , wherein the composition has a viscosity of about 5,000 cp to about 7,500 cp, as measured according to ASTM D1824-87.

9. The composition of claim 3 , wherein the composition has a viscosity of about 5,000 op to about 6,000 cp, as measured according to ASTM D1824-87.

10. The composition of claim 3 , wherein the thickener comprises hydroxyethylcellulose.

11. The composition of claim 3 , wherein the composition is in the form of a gelled matrix.

12. The composition of claim 3 , wherein the preservative comprises benzyl alcohol, benzalkonium chloride, disodium EDTA, and mixtures thereof.

13. The composition of claim 3 , wherein the preservative includes benzyl alcohol, benzalkonium chloride, an disodium EDTA.

14. The composition of claim 3 , wherein the permeation enhancer comprises a compound selected from the group consisting of liposomes, sequestering agents, ascorbic acid (Vitamin C), glycerol, chitosan, and lysophosphotidylcholin.

15. The composition of claim 3 , wherein the emulsion agent is selected from the group consisting of glycerolpolyethylene glycol ricinoleate, fatty acid esters of polyethyleneglycol, ethoxylated glycerol, polyethylene glycol, and mixtures thereof.

16. The composition of claim 3 , wherein the emulsion agent comprises hydroxylated lecithin.

17. The composition of claim 3 , wherein the buffer comprises disodium phosphate, monosodium phosphate, or mixtures thereof.

18. The composition of claim 3 , wherein the buffer comprises about 0.0001% to about 3.0% of disodium phosphate and 0.0001% to about 3.0% of monosodium phosphate.

19. A method of applying an effective amount of an active substance to a nasal membrane, the method comprising the steps of:

providing the composition of claim 3 ;

applying the composition in the nasal cavity; and

maintaining the composition in contact with the nasal membrane to reduce one or more symptoms associated with congestion.

20. A composition for application to a nasal membrane, the composition consisting of:

about 0.045 wt % to about 0.055 wt % oxymetazoline;

less than 5.0% by weight of at least one vitamin;

about 0.00001 wt % to about 5.0 wt % permeation enhancer;

about 0 wt % to about 1.0 wt % aromatic substance selected from the group consisting of camphor, eucalyptus oil, menthol, azulen, extracts thereof, and mixtures thereof;

0% to about 1.0% by weight of aloe vera powder;

about 0.0001 wt % to about 1.0 wt % preservative;

about 0.000001 to about 5.0 wt % thickener selected from the group consisting of glycerin, carrageenan, sugar, guar gum, methylcellulose, and hydroxyethylcellulose;

0.05% to about 5.0% by weight glycerin;

about 90 wt % to about 99 wt % water;

about 0.00001 wt % to about 1.0 wt % emulsion agent; and

about 0.0002 wt % to about 6.0 wt % buffer.

Assignments (13)
MERGER Recorded Jan 27, 2021
From: MATRIXX INITIATIVES, INC.
To: CHURCH & DWIGHT CO., INC.
Reel/Frame 055050/0307 →
MERGER Recorded Jan 27, 2021
From: ZICAM, LLC
To: MATRIXX INITIATIVES, INC.
Reel/Frame 055049/0961 →
RELEASE OF SECURITY AGREEMENT AT REEL/FRAME 044405/0405 Recorded Dec 2, 2020
From: MIDCAP FINANCIAL TRUST
To: ZICAM, LLC
Reel/Frame 054570/0923 →
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 2, 2020
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: ZICAM, LLC
Reel/Frame 054572/0670 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 19, 2017
From: ZICAM, LLC
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 044909/0361 →
RELEASE OF SECURITY INTEREST Recorded Dec 18, 2017
From: PROSPECT CAPITAL CORPORATION, AS AGENT
To: ZICAM, LLC
Reel/Frame 044422/0094 →
SECURITY INTEREST Recorded Dec 15, 2017
From: ZICAM, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 044405/0405 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 028468/0460 Recorded Dec 4, 2017
From: H.I.G. WONDER HOLDINGS, LLC
To: ZICAM, LLC
Reel/Frame 044681/0540 →
SECURITY AGREEMENT Recorded Aug 9, 2013
From: ZICAM, LLC
To: PROSPECT CAPITAL CORPORATION
Reel/Frame 030997/0895 →
TERMINATION AND RELEASE OF GRANT OF SECURITY INTEREST IN PATENT RIGHTS Recorded Aug 9, 2013
From: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
To: ZICAM, LLC
Reel/Frame 031003/0189 →
SUBORDINATE SECURITY INTEREST IN PATENT RIGHTS Recorded Jun 29, 2012
From: ZICAM, LLC
To: H.I.G. WONDER HOLDINGS, LLC
Reel/Frame 028468/0460 →
GRANT OF SECURITY INTEREST IN PATENT RIGHTS Recorded Jun 30, 2011
From: ZICAM, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 026533/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2004
From: CLAROT, TIM; HENSLEY, CHARLES
To: ZICAM, LLC
Reel/Frame 015880/0167 →
Continuity (2)
Provisional Application 6041064100 · Sep 13, 2002
Related Publication 20040166066A1 · Aug 26, 2004